Cold News and Research

RSS

International team builds comprehensive cancer models for future drug development

To develop new targeted treatments for cancer, scientists need tissue models that accurately represent the genetic and molecular traits of the cancer they're studying.

5 Aug 2026

Engineered spinal interneurons show promise for repairing spinal cord injuries

Spinal cord injuries affect an estimated 15 to 20 million people worldwide, often causing lasting impairments in movement, sensation, and independence.

5 Aug 2026

Patient-derived tumor models strengthen precision oncology research

A research project funded by the National Institutes of Health (NIH), with collaborators around the country and the world, has generated one of the most extensive and diverse collections of patient-derived tumor models.

5 Aug 2026

Immune cell changes provide new insights into long COVID

Extreme fatigue, a racing pulse, shortness of breath, brain fog, aching joints-the symptoms of long COVID can vary widely, change unpredictably, and be difficult to even recognize as signs of the condition.

2 Aug 2026

Pork supply chains may be shaping the global spread of drug-resistant Salmonella

Researchers linked 129,136 global human and swine Salmonella genomes with sampling from a Guangdong pork supply chain to examine how downstream stages relate to antimicrobial resistance. The study suggests slaughterhouse and retail interfaces may concentrate S. 4,[5],12:i:- ST34, resistant strains, and mobile resistance elements, supporting broader One Health surveillance beyond farms.

30 Jul 2026

This edible flower could do more than brighten a plate

A review of 76 publications finds that pot marigold contains more than 500 reported secondary metabolites, along with natural pigments, antioxidants, and substantial dietary fiber. Early food studies report promising results in yogurt, bread, pasta, and edible oils, but limited product trials and no clinical evidence currently prevent human health claims.

28 Jul 2026

New cancer vaccine harnesses COVID-19 immune memory to fight tumors

In a discovery that could redefine the future of cancer immunotherapy, scientists from Celloram Inc., University Hospitals and Case Western Reserve University have developed a novel cancer vaccine platform that transforms the impact of the largest immunological event in modern history – a synchronized mass immune memory generated through SARS-CoV-2 infection and vaccination – into a powerful ally against cancer.

27 Jul 2026

Novel bioinspired dressing uses body force to heal wounds

A bioinspired material, developed by scientists at Imperial College London, accelerates wound healing and the repair of human skin.

27 Jul 2026

Engineered probiotic bacteria boost immune attack against pancreatic cancer

Cancer immunotherapies have transformed treatment for many cancers, but pancreatic cancer remains especially difficult to treat. One major reason is that pancreatic tumors often create a "cold" tumor microenvironment, where the tumor prevents immune cells from mounting a strong attack.

24 Jul 2026

Study reveals dynamic remodeling of genome architecture during brain aging

Researchers have discovered that the human brain undergoes widespread age-related changes in genome regulation beginning in midlife that may help explain why aging is the greatest risk factor for neurodegenerative diseases such as Alzheimer's.

23 Jul 2026

Global hunger declines for third straight year but remains fragile, report reveals

Global hunger declined for a third consecutive year in 2025, demonstrating that progress is possible. However, the improvements remain fragile, unevenly distributed and insufficient to achieve the Sustainable Development Goals by 2030, according to The State of Food Security and Nutrition in the World 2026 (SOFI 2026) report, released on Tuesday by five United Nations specialized agencies.

22 Jul 2026

Wistar scientists develop new bispecific T cell engager to target ovarian cancer

Wistar scientists have developed a new type of bispecific T cell engager, or BTE, that is effective against ovarian cancer in preclinical studies.

21 Jul 2026

Specialized blood vessels enable effective immune defense against cancer metastases

It has long been suspected that endothelial cells, the specialized cells lining the inner walls of blood vessels, play a key role in determining how the body’s immune system responds to tumors.

20 Jul 2026

Targeting ZBP1 may overcome cancer immunotherapy resistance

A new Review published in the open-access journal Ferroptosis and Oxidative Stress highlights Z-nucleic acid-binding protein 1 (ZBP1) as an emerging innate immune sensor that converts genomic stress into potent antitumor immunity.

16 Jul 2026

Researchers rank 11 preeclampsia therapies as top candidates for further development

Researchers ranked 83 preclinical candidates for preventing or treating preeclampsia and eclampsia, identifying 11 as having high potential for further development. The analysis also revealed limited target diversity, moderate bias, inactive programs, and animal models that may not fully represent human pregnancy

15 Jul 2026

Integrating gene signatures and multi omics improves liver cancer treatment

Hepatocellular carcinoma (HCC) remains highly fatal due to late diagnosis and scarce early biomarkers.

14 Jul 2026

Cold-exposed mothers pass metabolic protection to male rat offspring through milk

Maternal cold exposure during early pregnancy improved glucose control and reduced liver fat in male rat offspring, with benefits persisting into late adulthood. The findings implicate a breast milk LCA, gut microbiota, and Th17 immune pathway, while human cohort data showed an observational link between winter conception and lower MASLD risk.

12 Jul 2026

Cruise ship pollution increases risk of viral infections in ports

Air pollution from cruise ships could be damaging the health of people living in port cities by increasing inflammation and susceptibility to viruses such as the common cold and COVID-19.

11 Jul 2026

Azenta announces completion of B Medical Systems sale to Thelema S.a r.l; Whitestone Group acquires a 40% Stake in Thelema S.a r.l, a Special Purpose Vehicle (SPV) established for the ownership of B Medical Systems

Azenta, Inc. today announced that it has closed its previously announced sale of B Medical Systems S.á r.l (BMS) to Thelema S.a r l.

From B Medical Systems S.à r.l 10 Jul 2026

Exposure to port-derived particles facilitates the replication of COVID-19 and cold viruses

Air pollution from cruise ships could be damaging the health of people living in port cities by increasing inflammation and susceptibility to viruses such as the common cold and COVID-19.

10 Jul 2026

Cold News and Research

International team builds comprehensive cancer models for future drug development

Engineered spinal interneurons show promise for repairing spinal cord injuries

Patient-derived tumor models strengthen precision oncology research

Immune cell changes provide new insights into long COVID

Pork supply chains may be shaping the global spread of drug-resistant Salmonella

This edible flower could do more than brighten a plate

New cancer vaccine harnesses COVID-19 immune memory to fight tumors

Novel bioinspired dressing uses body force to heal wounds

Engineered probiotic bacteria boost immune attack against pancreatic cancer

Study reveals dynamic remodeling of genome architecture during brain aging

Global hunger declines for third straight year but remains fragile, report reveals

Wistar scientists develop new bispecific T cell engager to target ovarian cancer

Specialized blood vessels enable effective immune defense against cancer metastases

Targeting ZBP1 may overcome cancer immunotherapy resistance

Researchers rank 11 preeclampsia therapies as top candidates for further development

Integrating gene signatures and multi omics improves liver cancer treatment

Cold-exposed mothers pass metabolic protection to male rat offspring through milk

Cruise ship pollution increases risk of viral infections in ports

Azenta announces completion of B Medical Systems sale to Thelema S.a r.l; Whitestone Group acquires a 40% Stake in Thelema S.a r.l, a Special Purpose Vehicle (SPV) established for the ownership of B Medical Systems

Exposure to port-derived particles facilitates the replication of COVID-19 and cold viruses

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News